Atlas Trials

Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients

Clinical trial NCT02626039 · COMPLETED

Trial details

NCT number
NCT02626039
Sponsor
Hospital General Universitario Gregorio Marañon
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Breast Cancer
Start date
2013-11-01
Primary completion
2018-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.